These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22593588)

  • 41. Turner syndrome, insulin sensitivity and growth hormone treatment.
    Mazzanti L; Bergamaschi R; Castiglioni L; Zappulla F; Pirazzoli P; Cicognani A
    Horm Res; 2005; 64 Suppl 3():51-7. PubMed ID: 16439845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Y chromosome in Turner syndrome: detection of hidden mosaicism and the report of a rare X;Y translocation case.
    Bispo AV; Burégio-Frota P; Oliveira dos Santos L; Leal GF; Duarte AR; Araújo J; Cavalcante da Silva V; Muniz MT; Liehr T; Santos N
    Reprod Fertil Dev; 2014 Oct; 26(8):1176-82. PubMed ID: 25294360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic imprinting and Turner syndrome.
    Bondy CA; Hougen HY; Zhou J; Cheng CM
    Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():728-32. PubMed ID: 22946286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA;
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4212-8. PubMed ID: 11095456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adult height in Turner Syndrome girls after long-term growth hormone treatment.
    Morin A; Guimarey LM; Apezteguia M; Santucci ZC
    Medicina (B Aires); 2009; 69(4):431-6. PubMed ID: 19770097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced spontaneous growth hormone secretion in patients with Turner's syndrome.
    Pirazzoli P; Mazzanti L; Bergamaschi R; Perri A; Scarano E; Nanni S; Zucchini S; Gualandi S; Cicognani A; Cacciari E
    Acta Paediatr; 1999 Jun; 88(6):610-3. PubMed ID: 10419243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of age and duration of growth hormone therapy in children with Turner syndrome.
    Ross J; Lee PA; Gut R; Germak J
    Horm Res Paediatr; 2011; 76(6):392-9. PubMed ID: 22156541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety of growth hormone treatment in pediatric patients with idiopathic short stature.
    Quigley CA; Gill AM; Crowe BJ; Robling K; Chipman JJ; Rose SR; Ross JL; Cassorla FG; Wolka AM; Wit JM; Rekers-Mombarg LT; Cutler GB
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5188-96. PubMed ID: 15899952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Identification and characterization of marker chromosome in Turner syndrome].
    Tan YQ; Cheng DH; DI YF; Li LY; Lu GX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):679-82. PubMed ID: 18241543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adult Height in 299 Patients with Turner Syndrome with or without Growth Hormone Therapy: Results and Literature Review.
    Dantas NCB; Braz AF; Malaquias A; Lemos-Marini S; Arnhold IJP; Silveira ER; Antonini SR; Guerra-Junior G; Mendonca B; Jorge A; Scalco RC
    Horm Res Paediatr; 2021; 94(1-2):63-70. PubMed ID: 34134112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group.
    Chernausek SD; Attie KM; Cara JF; Rosenfeld RG; Frane J
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2439-45. PubMed ID: 10902791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Analysis of the small supernumerary marker chromosome in Turner syndrome with 45, X/46, X, + mar karyotype].
    Ye ZC; Cai JG; Zhu XY; Zhao R; He XY; Zhong Y; Liu KX; Zhu YM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):461-4. PubMed ID: 20017317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Marker chromosome analysis in Chinese patients with Turner syndrome by fluorescence in situ hybridization].
    Liang Y; Luo XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):435-7. PubMed ID: 16086285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Descriptive analyses of Turner syndrome: 49 cases in Tunisia.
    Elleuch M; Mnif Feki M; Kammoun M; Charfi N; Rekik N; Bouraoui A; Kammoun T; Belguith N; Kammoun H; Sfar MT; Hachicha M; Abid M
    Ann Endocrinol (Paris); 2010 Mar; 71(2):111-6. PubMed ID: 20153455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. X chromosome parental origin and aortic stiffness in turner syndrome.
    Abd-Elmoniem KZ; Bakalov VK; Matta JR; Muldoon N; Hanover JA; Bondy CA; Gharib AM
    Clin Endocrinol (Oxf); 2014 Sep; 81(3):467-70. PubMed ID: 24796499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth Hormone Treatment to Final Height in Turner Syndrome: Systematic Review.
    Aversa T; Li Pomi A; Pepe G; Corica D; Messina MF; Coco R; Sippelli F; Ferraloro C; Luppino G; Valenzise M; Wasniewska MG
    Clin Ther; 2024 Feb; 46(2):146-153. PubMed ID: 38151406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.